Data as of Apr 17
| +0.72 / +1.04%|
The 24 analysts offering 12-month price forecasts for Gilead Sciences Inc have a median target of 99.50, with a high estimate of 132.00 and a low estimate of 63.00. The median estimate represents a +42.14% increase from the last price of 70.00.
The current consensus among 29 polled investment analysts is to Buy stock in Gilead Sciences Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.